Holen Sie sich die Stockscreener-App
0.8058
2.00%
0.0158
Schlusskurs vom Vortag:
$0.79
Offen:
$0.815
24-Stunden-Volumen:
14,509
Relative Volume:
0.16
Marktkapitalisierung:
$44.84M
Einnahmen:
$117.93M
Nettoeinkommen (Verlust:
$5.00M
KGV:
6.1324
EPS:
0.1314
Netto-Cashflow:
$-12.91M
1W Leistung:
-1.76%
1M Leistung:
-10.47%
6M Leistung:
-48.68%
1J Leistung:
-49.00%
1-Tages-Spanne:
$0.8149
$0.82
1-Wochen-Bereich:
$0.79
$0.8615
52-Wochen-Spanne:
$0.68
$1.7698
Intercure Ltd Stock (INCR) Company Profile
Compare INCR vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
0.82 | 43.20M | 117.93M | 5.00M | -12.91M | 0.1314 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.82 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.28 | 48.74B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.06 | 44.85B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.66 | 34.12B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
539.55 | 23.35B | 3.13B | 1.27B | 1.12B | 26.39 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-18 | Hochstufung | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Aktie (INCR) Neueste Nachrichten
Aug Highlights: What are analysts price targets for InterCure LtdTreasury Yields & Accurate Intraday Trade Tips - baoquankhu1.vn
Market Fear: Is HCAT stock forming a triangle patternProduct Launch & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Will InterCure Ltd. stock split again soon2025 Analyst Calls & Daily Entry Point Trade Alerts - Naître et grandir
Aug Analyst Calls: Is InterCure Ltd a potential multi baggerWeekly Trade Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
INCR,UMBF Revenue Breakdown - Finviz
InterCure receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Canada
InterCure receives Nasdaq notice for minimum bid price deficiency - Investing.com South Africa
InterCure Faces Nasdaq Compliance Deadline After Bid-Price Breach - TipRanks
InterCure Receives Noncompliance Notice From Nasdaq - marketscreener.com
InterCure receives Nasdaq notification regarding minimum bid requirement - marketscreener.com
Nasdaq warns InterCure (Nasdaq: INCR) on sub-$1 share price and listing - Stock Titan
InterCure Ltd. Receives Nasdaq Compliance Notice Due to Bid Price Deficiency, Plans to Regain Compliance - Quiver Quantitative
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement - GlobeNewswire
INCR Technical Analysis & Stock Price Forecast - Intellectia AI
Earnings Recap: Will RDACU outperform its industry peersJuly 2025 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
What’s the fair value of InterCure Ltd. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
Bearish Setup: Is InterCure Ltd being accumulated by smart money2025 Market Overview & Safe Capital Preservation Plans - baoquankhu1.vn
InterCure reports 11% revenue growth for 2025, enters German market By Investing.com - Investing.com Nigeria
InterCure reports 11% revenue growth for 2025, enters German market - Investing.com
InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans - TipRanks
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - markets.businessinsider.com
Cannabis grower InterCure rebounds from Gaza war damage to NIS 265M sales - Stock Titan
Risk Check: Why is InterCure Ltd stock going up2025 Top Decliners & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Why is InterCure Ltd. stock going upQuarterly Profit Report & Technical Buy Zone Confirmations - mfd.ru
What are InterCure Ltd.’s growth leversJuly 2025 Sentiment & Safe Entry Trade Signal Reports - mfd.ru
Hedge Fund Bets: Will InterCure Ltd. benefit from green energy policies2025 Volatility Report & Low Risk Investment Opportunities - baoquankhu1.vn
InterCure faces NIS 27 million exposure as key cannabis partner Bazelet enters restructuring - MSN
Head-To-Head Contrast: InterCure (NASDAQ:INCR) versus CompuMed (OTCMKTS:CMPD) - Defense World
Quarterly Trades: Is InterCure Ltd exposed to currency risks2025 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Top Cannabis Stocks To Watch TodayJanuary 1st - MarketBeat
Does InterCure Ltd. stock benefit from AI growthWeekly Profit Report & Risk Controlled Daily Trade Plans - mfd.ru
RSI Check: Is InterCure Ltd undervalued by DCF analysisMarket Movers & Low Risk Entry Point Tips - baoquankhu1.vn
Surprises Report: Is InterCure Ltd a potential multi baggerWeekly Loss Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Why Investors Shouldn't Be Surprised By InterCure Ltd.'s (TLV:INCR) 29% Share Price Plunge - simplywall.st
Will InterCure Ltd. stock gain from strong economyEarnings Recap Summary & Community Trade Idea Sharing Platform - Улправда
Published on: 2026-01-12 07:36:04 - ulpravda.ru
Can InterCure Ltd. stock attract ESG capital inflows2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Улправда
Will InterCure Ltd. stock attract ESG investorsJuly 2025 Gainers & Smart Swing Trading Alerts - Улправда
Top Cannabis Stocks To Watch Today – January 1st - Defense World
Wall Street Recap: How InterCure Ltd stock compares to market leadersJuly 2025 Technicals & Stepwise Swing Trade Plans - moha.gov.vn
InterCure (NASDAQ:INCR) Shares Down 6.6% – Should You Sell? - Defense World
InterCure Shareholders Approve All Proposals at 2025 Annual Meeting - TipRanks
InterCure shareholders approve all proposals at 2025 annual meeting - MSN
We Discuss Why InterCure Ltd.'s (TLV:INCR) CEO Compensation May Be Closely Reviewed - simplywall.st
Why InterCure Ltd. stock could see breakout soonInterest Rate Changes & Zero-Cost Stock Research by Professionals - bollywoodhelpline.com
Critical Contrast: InterCure (NASDAQ:INCR) & Varex Imaging (NASDAQ:VREX) - Defense World
Is InterCure Ltd. stock a buy for dividend growthJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
How InterCure Ltd. stock compares to market leaders2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Finanzdaten der Intercure Ltd-Aktie (INCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
1.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):